Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
収録刊行物
-
- International Journal of Antimicrobial Agents
-
International Journal of Antimicrobial Agents 55 (5), 105954-, 2020-05
Elsevier BV